Thomson Medical Centre (5FV.SG) +4.2% at almost three-year high of $0.75 on above-average volume as investors drawn to healthcare group’s steady, defensive earnings profile amid recent broad market volatility, according to Dow Jones.

Net profit for fiscal 3Q10 ended May +38.7% on-year at $4.8 million as revenue +25.4% at $21.8 million. Balance sheet healthy with cash hoard at $24.3 million vs $15.2 million year earlier, net cash from operations at $15.2 million vs $12.3 million in 3Q09. Debt insignificant with only $1.7 million in loans.

“While some may view Thomson Medical’s operations as smaller and more focused compared to peers, we are of the view that the niche operations make it more stable,” says DMG; has Buy call with $0.88 target. Orderbook quotes suggest resistance at $0.77.